How to go sober at Christmas, from people who know
Christmas and booze often go hand-in-hand, so how do you say no, no, no when the drinks start to flow?
Christmas and booze often go hand-in-hand, so how do you say no, no, no when the drinks start to flow?
CNN anchor Sara Sidner shared on Monday that she is currently undergoing treatment for stage 3 breast cancer. Sidner, 51, announced her diagnosis during an emotional segment of “CNN News Central,” which she co-hosts. Sidner told viewers she is in her second month of chemotherapy and will undergo radiation and a double mastectomy. “I have…
The Food and Drug Administration has approved Narcan, a naloxone nasal spray that can reverse opioid overdoses and save lives, for over-the-counter use. In an announcement Wednesday, FDA Commissioner Robert M. Califf said the move is meant to address a “dire public health need” and will help increase access and reduce opioid overdose deaths in…
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial. Those positive results for diabetes patients suffering…
With flu season in full swing — and other seasonal respiratory infections also spiking across the U.S. — experts say it’s important to keep your immune system strong and healthy during this time of year. One way to combat seasonal illness is to regularly consume key nutrients and proteins that help improve immune health, according…
In the tapestry of modern challenges, climate change stands as a colossus, casting a long shadow over our collective future. Yet, within this challenge lies an unprecedented opportunity for the corporate world to spearhead a revolution, not just in how businesses operate, but in how they can galvanize global efforts towards sustainability. As the clarion…
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their sleeves for an updated version of the jab. The revenue from the shots met Moderna’s forecast for the year, even as sales plummeted from the…